Effective Protection Against Status Epilepticus Caused by Lithium–Pilocarpine: Combination of Midazolam and Lacosamide
ABSTRACT Aim Status epilepticus causes the most severe condition related to epilepsy in terms of high mortality rate. Although status epilepticus treatment guidelines specify a treatment process based on three‐stage monotherapy, effective control cannot yet be achieved in all cases. In the presented...
Saved in:
| Main Authors: | Cumaali Demirtas, Metehan Akca, Ugur Aykin, Yunus Emre Surmeneli, Hava Yildirim, Mehmet Yildirim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Brain and Behavior |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/brb3.70546 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategies to innovate emergency care of status epilepticus
by: Jaideep Kapur
Published: (2025-01-01) -
Glucose utilisation during status epilepticus in an epilepsy model induced by pilocarpine: a qualitative study
by: Scorza Fulvio Alexandre, et al.
Published: (2002-01-01) -
Refinement of the pilocarpine-induced status epilepticus model in mice to improve mortality outcomes
by: Mi Jiang, et al.
Published: (2025-05-01) -
Levetiracetam versus phenytoin/fosphenytoin for second-line treatment of children with convulsive status epilepticus: an up-to-date meta-analysis and systematic review of randomized controlled trials
by: Linping Jin, et al.
Published: (2025-05-01) -
Midazolam infusions for therapeutic management of pediatric refractory status epilepticus: a systematic review
by: K. Taneille Johnson, et al.
Published: (2025-04-01)